Major drug partnership aims to develop new cancer drug
Under the terms of the partnership between MEI Pharma and Helsinn, the latter will develop and market the former's cancer drug targeting acute myeloid leukemia.
Under the terms of the partnership between MEI Pharma and Helsinn, the latter will develop and market the former's cancer drug targeting acute myeloid leukemia.